Bioventix (BVXP)

Sector:

Pharma and Biotech

Index:

FTSE AIM 100

2,425.00p
   
  • Change Today:
      5.00p
  • 52 Week High: 4,750.00
  • 52 Week Low: 2,400.00
  • Currency: UK Pounds
  • Shares Issued: 5.22m
  • Volume: 5,063
  • Market Cap: £126.58m
  • Beta: 0.00

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth
22.85% below the market average22.85% below the market average22.85% below the market average22.85% below the market average22.85% below the market average
40% below the sector average40% below the sector average40% below the sector average40% below the sector average40% below the sector average
1yr Revenue Growth
10.05% above the market average10.05% above the market average10.05% above the market average10.05% above the market average10.05% above the market average
6.67% below the sector average6.67% below the sector average6.67% below the sector average6.67% below the sector average6.67% below the sector average

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield
57.10% above the market average57.10% above the market average57.10% above the market average57.10% above the market average57.10% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
1yr DPS Growth
37.18% below the market average37.18% below the market average37.18% below the market average37.18% below the market average37.18% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio
39.65% above the market average39.65% above the market average39.65% above the market average39.65% above the market average39.65% above the market average
42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average
Price Book Ratio
92.56% below the market average92.56% below the market average92.56% below the market average92.56% below the market average92.56% below the market average
76.74% below the sector average76.74% below the sector average76.74% below the sector average76.74% below the sector average76.74% below the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
75.98% below the market average75.98% below the market average75.98% below the market average75.98% below the market average75.98% below the market average
30.61% below the sector average30.61% below the sector average30.61% below the sector average30.61% below the sector average30.61% below the sector average
Price Chg 3m
69.69% below the market average69.69% below the market average69.69% below the market average69.69% below the market average69.69% below the market average
22.45% below the sector average22.45% below the sector average22.45% below the sector average22.45% below the sector average22.45% below the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
45.99% below the market average45.99% below the market average45.99% below the market average45.99% below the market average45.99% below the market average
30.43% below the sector average30.43% below the sector average30.43% below the sector average30.43% below the sector average30.43% below the sector average
Momentum 20
98.57% below the market average98.57% below the market average98.57% below the market average98.57% below the market average98.57% below the market average
95.65% below the sector average95.65% below the sector average95.65% below the sector average95.65% below the sector average95.65% below the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
75.89% above the market average75.89% above the market average75.89% above the market average75.89% above the market average75.89% above the market average
94.29% above the sector average94.29% above the sector average94.29% above the sector average94.29% above the sector average94.29% above the sector average
ROCE
79.72% above the market average79.72% above the market average79.72% above the market average79.72% above the market average79.72% above the market average
60.00% above the sector average60.00% above the sector average60.00% above the sector average60.00% above the sector average60.00% above the sector average

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
91.27% above the market average91.27% above the market average91.27% above the market average91.27% above the market average91.27% above the market average
87.50% above the sector average87.50% above the sector average87.50% above the sector average87.50% above the sector average87.50% above the sector average
Forecast EPS
80.79% above the market average80.79% above the market average80.79% above the market average80.79% above the market average80.79% above the market average
55.56% above the sector average55.56% above the sector average55.56% above the sector average55.56% above the sector average55.56% above the sector average

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
35.66% below the market average35.66% below the market average35.66% below the market average35.66% below the market average35.66% below the market average
8.57% above the sector average8.57% above the sector average8.57% above the sector average8.57% above the sector average8.57% above the sector average
Operating Profit Loss
26.19% above the market average26.19% above the market average26.19% above the market average26.19% above the market average26.19% above the market average
79.17% above the sector average79.17% above the sector average79.17% above the sector average79.17% above the sector average79.17% above the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
25.38% below the market average25.38% below the market average25.38% below the market average25.38% below the market average25.38% below the market average
8.70% above the sector average8.70% above the sector average8.70% above the sector average8.70% above the sector average8.70% above the sector average
Cash
10.56% below the market average10.56% below the market average10.56% below the market average10.56% below the market average10.56% below the market average
2.13% above the sector average2.13% above the sector average2.13% above the sector average2.13% above the sector average2.13% above the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y Not Available
Buys 1y
75.06% below the market average75.06% below the market average75.06% below the market average75.06% below the market average75.06% below the market average
86.21% below the sector average86.21% below the sector average86.21% below the sector average86.21% below the sector average86.21% below the sector average

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy Not Available
Brokers Percent Neutral Not Available

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Bioventix Market Data

Currency UK Pounds
Share Price 2,425.00p
Change Today 5.00p
% Change 0.21 %
52 Week High 4,750.00
52 Week Low 2,400.00
Volume 5,063
Shares Issued 5.22m
Market Cap £126.58m
Beta 0.00

Bioventix Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
39.09% below the market average39.09% below the market average39.09% below the market average39.09% below the market average39.09% below the market average
87.50% above the sector average87.50% above the sector average87.50% above the sector average87.50% above the sector average87.50% above the sector average
Price Trend
73.22% below the market average73.22% below the market average73.22% below the market average73.22% below the market average73.22% below the market average
42.86% below the sector average42.86% below the sector average42.86% below the sector average42.86% below the sector average42.86% below the sector average
Income
40.84% above the market average40.84% above the market average40.84% above the market average40.84% above the market average40.84% above the market average
42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average
Growth
26.24% below the market average26.24% below the market average26.24% below the market average26.24% below the market average26.24% below the market average
29.03% below the sector average29.03% below the sector average29.03% below the sector average29.03% below the sector average29.03% below the sector average

Bioventix Dividends

  Latest Previous
  1st Interim 2nd Interim
Ex-Div 10-Apr-25 07-Nov-24
Paid 25-Apr-25 21-Nov-24
Amount 70.00p 87.00p

Trades for 01-Apr-2025

Time Volume / Share Price
16:49 1,100 @ 2,416.30p
16:38 1,000 @ 2,400.00p
16:29 10 @ 2,407.00p
16:05 10 @ 2,410.00p
15:17 10 @ 2,413.44p

Bioventix Key Personnel

CEO Peter John Harrison
Chair Ian James Nicholson
CFO Bruce Hiscock

Top of Page